On this page

What was reported

On August 12, the University of Wisconsin–Madison publicized a Nature Communications study of imidazole propionate (ImP), a metabolite produced when some gut bacteria process histidine. The paper analyzed human cohort data and experimental models.

Findings

Among 1,196 cognitively unimpaired adults, higher plasma ImP was associated with lower preclinical cognitive scores and Alzheimer-related biomarkers. In mice, chronic ImP exposure worsened Alzheimer-like pathology; cell experiments also found effects on brain endothelial barrier integrity and tau phosphorylation.

Limits and date distinction

The human findings are associations, while causal effects came from mouse and cell experiments; this does not show that avoiding histidine-containing foods prevents dementia. The journal paper was published June 26, 2026, with a version-of-record date of August 10; August 12 is the separate university announcement date used here.

This sourced news summary and translation were prepared with AI assistance. Source links, the news date and research limitations are disclosed; this is not a claim of independent medical expert review. News production method.

Sources

Research news is not medical advice or a recommendation to use a substance. Read findings in the context of the study design, participants and limitations. Editorial standards.

← All news